Adaptive Biotechnologies (ADPT) Announces CFO Resignation

On April 1, 2024, the Chief Financial Officer of Adaptive Biotechnologies (NASDAQ: ADPT) Tycho Peterson submitted his resignation. The resignation was voluntary and not due to any disagreement with the Company on any matter relating to its operations, policies or practices. Mr. Peterson’s planned departure date from the Company is April 5, 2024. Kyle Piskel, who has been with Company for 8 years and is currently its Principal Accounting Officer will serve as the Chief Financial Officer starting on April 8, 2024.

You May Also Be Interested In

• Exchange Bank declares Q3 dividend, CEO to retire in 2027
• Vivos Therapeutics opens sleep center in Henderson, Nevada
• Troops Inc. disputes short-seller report amid Hong Kong court proceedings